BackBlack Bird Biotech Overview

Black Bird Biotech Other Liabilities

Black Bird Biotech's other liabilities is $0.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00
↓ 100.00% YoYΔ $718760.00 vs prior year quarter

Peer average

Loading

Black Bird Biotech Other Liabilities History

Loading

Black Bird Biotech vs. peers: Other Liabilities Comparison

Loading

Black Bird Biotech Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Black Bird Biotech (BBBT) FAQ

As of the most recent data (September 2023), BBBT shows a other liabilities of $0. That compares with $-720K in the prior-year period — up 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BBBT's other liabilities is now $0 (was $-720K) — a 100.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Black Bird Biotech is outperforming or lagging.

Tracking BBBT's other liabilities over time shows whether Black Bird Biotech is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $-720K in the prior-year period — up 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other liabilities page, Stockcircle has Black Bird Biotech's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other liabilities (currently $0) with ownership activity and broader fundamentals.